Skip to main navigation
Skip to search
Skip to main content
Mayo Clinic Home
Home
Profiles
Departments/Divisions
Grants
Research output
Prizes
Search by expertise, name or affiliation
New therapeutics for primary hyperoxaluria type 1
Pegah Dejban,
John C. Lieske
Nephrology and Hypertension
Research output
:
Contribution to journal
›
Review article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'New therapeutics for primary hyperoxaluria type 1'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Primary hyperoxaluria type 1
100%
Oxalates
79%
L-Lactate Dehydrogenase
17%
glycollate oxidase
16%
Oxalobacter formigenes
16%
stiripentol
15%
Liver
13%
Hyperoxaluria
12%
Lanthanum
12%
Nephrocalcinosis
12%
Nephrolithiasis
11%
Clustered Regularly Interspaced Short Palindromic Repeats
9%
Therapeutics
9%
Kidney Transplantation
8%
Anticonvulsants
8%
Inborn Genetic Diseases
8%
Chronic Renal Insufficiency
7%
Liver Transplantation
7%
Renal Insufficiency
7%
Gastrointestinal Tract
7%
RNA
6%
Bacteria
5%
Morbidity
5%
Enzymes
4%
Mortality
4%